Answer
Yes. It is a bispecific antibody that redirects the patient’s T cells towards CD20-bearing B cells.
Sources for this answer
- Columvi 2.5 mg, 10 mg concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.